CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $392,144
- in 8 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Celano Michael Chief Financial Officer | Purchase | +18,460 | $2.71 | $50K | 234,245 |
| 2026-01-26 | Celano Michael Chief Financial Officer | Grant or award | +37,604 | 215,785 | ||
| 2026-01-26 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +225,622 | 225,622 | ||
| 2025-01-22 | Celano Michael Chief Financial Officer | Grant or award | +34,185 | 178,181 | ||
| 2025-01-22 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +205,111 | 205,111 | ||
| 2024-01-17 | Celano Michael Chief Financial Officer | Grant or award | +31,250 | 143,996 | ||
| 2024-01-17 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +187,500 | 187,500 | ||
| 2023-05-17 | Celano Michael Chief Financial Officer | Purchase | +5,000 | $3.73 | $19K | 112,746 |
| 2023-01-31 | Celano Michael Chief Financial Officer | Grant or award | +76,000 | 107,746 | ||
| 2023-01-31 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2022-09-16 | Celano Michael Chief Financial Officer | Purchase | +31,746 | $3.15 | $100K | 31,746 |
| 2022-05-10 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-01-18 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-01-19 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2020-09-29 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (right to buy) | +84,100 | 84,100 | ||
| 2020-05-28 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,479 | 60,479 |
Page 1 of 1 · 16 trades